Categories and tags
Categories
- From the Industry (2)
- From the Literature (1,036)
- News (20)
- Other NATA Events (4)
- Past NATA Symposia (20)
- Reviewed articles (38)
- Symposium Highlights (6)
- Unclassed (21)
Tags
ACTIVATED FACTOR-VII (14)
ACUTE NORMOVOLEMIC HEMODILUTION (17)
ANEMIA (24)
ANH (12)
autologous blood (11)
autotransfusion (11)
bleeding (13)
BLOOD (12)
BLOOD-COAGULATION (8)
BLOOD-TRANSFUSION (21)
blood loss (8)
blood substitutes (10)
CANCER (12)
CARDIAC-SURGERY (17)
cardiopulmonary bypass (12)
COAGULATION (15)
EFFICACY (7)
erythropoietin (12)
Factor VIIa (11)
HEMODILUTION (14)
hemophilia (8)
HEMOPHILIA-A (12)
HEMORRHAGE (19)
hemostasis (16)
INHIBITORS (10)
MANAGEMENT (11)
NovoSeven (47)
NOVOSEVEN(R) (9)
oncology (8)
oxygen carriers (8)
PATIENT (12)
PLASMA (8)
RECOMBINANT-HUMAN-ERYTHROPOIETIN (15)
RECOMBINANT FACTOR VIIA (31)
rFVIIa (63)
RISK (11)
risks (8)
safety (15)
SURGERY (31)
survival (7)
THERAPY (20)
TISSUE FACTOR (9)
TRANSFUSION (33)
Trauma (11)
TRIAL (7)
Most recent posts
Time is Right for Restrictive Transfusion Strategy in ECMO
Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely…
F11a and FX12a Inhibitors – the Next Wave of Novel Anticoagulants?
Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components…
Meta-Analysis Backs up TXA Safety in Patients at Risk of Thrombosis
Tranexamic acid (TXA) is safe to use to prevent bleeding in patients at the time of surgery, even in those…
Measuring the Success of PBM in Practice – Lessons from Spain
According to the World Health Organisation, widespread implementation of patient blood management (PBM) programmes remains an urgent need.1 It is…
Diversity of PBM Reflected in Scientific Programme
There will be something for everyone in this year’s Scientific Programme, according to Sigismond Lasocki (University Hospital Angers, France), the…